Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus

被引：10
|
作者：
Dvorak, C. C. [1 ]
Callard, E. [1 ]
Agarwal, R. [1 ]
机构：
[1] Stanford Univ, Sch Med, Div Pediat Stem Cell Transplantat, Palo Alto, CA 94304 USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 03期
关键词：
D O I：
10.1038/sj.bmt.1705422
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
    C C Dvorak
    E Callard
    R Agarwal
    Bone Marrow Transplantation, 2006, 38 : 253 - 254
  • [2] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    TRANSPLANTATION, 1999, 67 (04) : 499 - 504
  • [3] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [4] Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients
    Kiehl, MG
    Schäfer-Eckart, K
    Kröger, M
    Bornhäuser, M
    Basara, N
    Blau, IW
    Kienast, J
    Fauser, AA
    Ehninger, G
    Armstrong, VW
    Shipkova, M
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2922 - 2924
  • [5] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    de Lavallade, H
    Faucher, C
    Bilger, K
    Vey, N
    Stoppa, AM
    Gravis, G
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
  • [6] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [7] Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant
    Mirza, Sayeef
    Tandon, Ankita
    Jenneman, Dakota
    Cao, Shu
    Kumar, Ambuj
    Kidd, Michelle R.
    Khimani, Farhad
    Mishra, Asmita
    Liu, Hien D.
    Nishihori, Taiga
    Perez, Lia
    Bejanyan, Nelli
    Pidala, Joseph
    Nieder, Michael
    Elmariah, Hany
    BLOOD, 2019, 134
  • [8] Daclizumab (DAC) ± mycophenolate mofetil (MMF) for control of graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients with cyclosporine or tacrolimus intolerance.
    Abhyankar, S
    Day, SD
    Barnhart, C
    Belt, RJ
    McGuirk, JP
    BLOOD, 2001, 98 (11) : 353B - 353B
  • [9] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    I Haentzschel
    J Freiberg-Richter
    U Platzbecker
    A Kiani
    J Schetelig
    T Illmer
    G Ehninger
    E Schleyer
    M Bornhäuser
    Bone Marrow Transplantation, 2008, 42 : 113 - 120
  • [10] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Haentzschel, I.
    Freiberg-Richter, J.
    Platzbecker, U.
    Kiani, A.
    Schetelig, J.
    Illmer, T.
    Ehninger, G.
    Schleyer, E.
    Bornhaeuser, M.
    BONE MARROW TRANSPLANTATION, 2008, 42 (02) : 113 - 120
12345